How market wizard Anil Singhvi views Hindalco, Divi's, Hindustan Copper, other stocks today
Zee Business Managing Editor Anil Singhvi shares his thoughts on a bunch of stocks. Here's what the market wizard suggests on Hindalco, Hindustan Zinc, Aurobindo Pharma, and Glenmark Pharma.
As the bulls take domestic equity benchmarks Sensex and Nifty50 to fresh peaks, Zee Business Managing Editor Anil Singhvi shares his thoughts on a bunch of stocks.
Here's what the market wizard suggests investors do with stocks such as Hindalco Industries, Glenmark Pharma, Aurobindo Pharma (AUROPHARMA), Divi's Labs (DIVISLAB), and United Spirits (UNITDSPR).
Buy Aurobindo Pharma futures: Anil Singhvi
The market wizard suggests buying Aurobindo Pharma futures for targets of Rs 1,247, Rs 1,260 and Rs 1,275 with a stop loss at Rs 1,217.
Aurobindo Pharma stages second back-to-back quarterly performance: Anil Singhvi
The market guru points out that the drug maker staged a strong operational performance in the March quarter, with robust growth across segments.
United Spirits results a mixed bag: Anil Singhvi
The market wizard suggests investors wait for the beverage alcohol maker's management commentary scheduled at 3:30 pm on Monday.
NTPC results a mixed bag: Anil Singhvi
The market guru expects some weakness to emerge in NTPC shares and suggests buying the stock at lower levels.
Brokerages positive on Hindalco post-results on Friday: Anil Singhvi
Hindalco Industries registered a 32 per cent year-on-year jump in its consolidated net profit to Rs 3,174 crore for the March quarter. While its quarterly EBITDA grew about one-fourth to Rs 6,682 crore, its margin improved by 250 bps to 12 per cent.
Jefferies maintained its 'buy' call on Hindalco Industries after the earnings announcement and raised its target price for the stock by Rs 15 to Rs 825.
Glenmark Pharma results miss estimates in all aspects: Anil Singhvi
The market wizard highlights that although the pharma firm's financial results fell short of analysts' expectations on all fronts, its margin and EBITDA looked strong.
He believes a 3-5 per cent fall will provide a good opportunity to buy the stock.
Buy Hindustan Copper shares: Anil Singhvi
The market guru suggests buying Hindustan Copper shares in the spot market for targets of Rs 377, Rs 382 and Rs 388 with a stop loss at Rs 365.
He pointed out that the metal giant staged a strong financial performance in all aspects with its margin hitting the highest level recorded in 11 quarters.
Buy Cochin Shipyard shares: Anil Singhvi
The market wizard suggests buying Cochin Shipyard shares for targets of Rs 1,950, Rs 1,990 and Rs 2,025
with a stop loss at Rs 1,900.
Cochin Shipyard staged exceptionally strong quarterly results with a 660 per cent jump in its net profit and a 100 per cent jump in revenue, though the stock has rallied 35 per cent in five days and 120 per cent in three months, he adds.
Buy Torrent Pharma futures: Anil Singhvi
The market guru suggests Torrent Pharma futures for targets of for targets of Rs 2,675, Rs 2,695 and Rs 2,740 with a stop loss at Rs 2,595.
The company staged an improvement in its operational performance with a strong outlook, he pointed out.
Buy Divi’s Labs futures: Anil Singhvi
The market guru suggests buying Divi’s Labs futures for targets of Rs 4,185, Rs 4,225 and Rs 4,290 with a stop loss at Rs 4,110, citing a strong financial performance by the company after several quarters.